Noble treatment for PTSD


Xenon may one day become a promising new treatment for post-traumatic stress disorder (PTSD) following an investigation by researchers at Harvard Medical School, US.

Edward Meloni and colleagues exposed a group of 94 rats to frightening stimuli. Rats who were administered xenon gas during a critical period of time known as the reconsolidation window – when reactivated memories become temporarily susceptible to modification – showed less fear than those who were not.

Xenon achieved this effect by inhibiting glutamatergic NMDA receptors in the brain, involved in memory reconsolidation. Exposure to xenon gas at just the right time interrupts the reconsolidation process and prevents the recollection of powerful emotions such as fear.

If similar effects are seen in humans, xenon gas could be used to help individuals suffering from PTSD.  This treatment is particularly exciting because xenon has already been shown to be safe in humans, thanks to its use as an anaesthetic and diagnostic imaging agent.


Related Content

Of mice and men

30 March 2011 Premium contentFeature

news image

2009 marked the first year that more genetically modified animals were used in UK scientific procedures than animals deemed '...

Bacterium altered to suppress hunger faces long road to clinic

24 March 2015 Research

news image

Engineered microbes produce anti-obesity molecule in mice, but moving to humans poses challenges

Most Read

Flushing advice is flawed

24 August 2015 Research

news image

Protocols to restore contaminated water supplies are not based on science

Simple chemistry saving thousands of gold miners from mercury poisoning

25 August 2015 News and Analysis

news image

Basic apparatus is cutting mercury pollution and helping Indonesian miners go for gold

Most Commented

Paper device tracks fracking pollution

21 August 2015 Research

news image

Cheap and simple bromide sensor warns if water has been contaminated with fracking fluid

New drug treatment for alcoholism shows promise in animal studies

24 August 2015 Research

news image

Compounds that target a receptor in the brain appear less addictive with fewer negative side-effects than existing drugs